Answers are grounded in this paper and cite their sources.
Radiofrequency ablation (RFA) of leiomyomas represents a significant advancement in the treatment of this common uterine condition. In the appropriately selected patient, both laparoscopic and transcervical options provide effective treatment for bleeding and bulk symptoms in a uterine-sparing manner. Compared with other minimally invasive leiomyoma treatment options, RFA procedures have comparable or favorable safety profiles, recovery timelines, and reintervention rates. Data on future fertility and pregnancy are limited, although early reports are promising.
No takes yet. Share an insight, caveat, or question.
Stewart et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: